The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment with Ranolazine will improve
exercise capacity in patients with Heart Failure with preserved left ventricular ejection
fraction, or HFPEF.